Crossmark

Hyperoxia-Preconditioned Human ESC Line KIND1, Predominantly Differentiated into SP-C+ Type-II Alveolar Epithelial Cells, Reduces Idiopathic Pulmonary Fibrosis in Mice

Crossref DOI link: https://doi.org/10.1007/s12595-023-00475-4

Published Online: 2023-04-26

Published Print: 2023-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mitra, Shinjini https://orcid.org/0000-0001-8252-6847
Banerjee, Ena Ray https://orcid.org/0000-0002-6180-4825
Funding

Funding for this research was provided by:

Indian Council of Medical Research

University Grants Commission
License Information

Text and Data Mining valid from 2023-04-26

Version of Record valid from 2023-04-26
More Information

Article History

Received: 4 July 2022

Revised: 22 March 2023

Accepted: 7 April 2023

First Online: 26 April 2023

Declarations

:

: There is no conflict of interest among the authors.

Document is current

Any future updates will be listed below